An assessment of the NIH Women's Health Initiative /
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Book |
| Language: | English |
| Published: |
Washington, D.C. :
National Academy Press,
1993.
|
| Subjects: | |
| Online Access: | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=14118 |
Table of Contents:
- (cont) Threats to completion of HRT branch
- Use of HRT in elderly women
- Calcium and vitamin D supplement branch
- Rationale
- Design and methods
- Threats to successful completion of CaD branch
- Clinical trial cost
- Data available to committee deliberations
- WHI cost relative to other larger studies
- Clinical center funding
- Total cost
- Potential causes of budget shortfalls
- Observational study
- Rationale
- Design and method
- Cost
- Recommendations
- Community prevention study
- Rationale
- Design and methods
- Cost
- Recommendations
- Concluding remarks
- Response to the statement of task
- Societal context
- Efficacy and effectiveness
- Public health choice versus individual choice
- Considerations beyond science
- Clinical trial exclusion criteria
- U.S. House of Representatives Appropriations Committee
- Statement of task
- Documents received by the Institute of Medicine from the National Institutes of Health
- Meeting participants June, July and August 1993
- Primary and subsidiary hypotheses of the women's health initiative clinical trial.
- (cont) Women's health initiative committees
- NIH-sponsored women's health studies
- NIH cost and FTE summary for Vanguard clinical centers
- NIH power calculations
- Women's health initiative clinical coordinating center and Vanguard clinical centers principal investigators
- Abbreviations and acronyms
- Committee and staff biographies.